News

Eptinezumab May Significantly Reduce Migraine-Related Burden in Chronic Migraine

Publish Date July 18, 2019

Eptinezumab treatment for chronic migraine was associated with significant reduction in migraine-related burden on work, home, and social functioning.

Non-Invasive Device Stimulating Occipital and Trigeminal Nerves Effectively Treats Acute Migraine

Publish Date July 18, 2019

Combined stimulation of the occipital and trigeminal nerves using a non-invasive stimulation device was found to be effective for the acute treatment of migraine.

Oral Atogepant May Reduce Mean Monthly Migraine Days

Publish Date July 18, 2019

Atogepant was found to be safe and effective for reducing the mean monthly migraine days.

Single-Dose Rimegepant Provides Rapid, Sustained Relief From Migraine

Publish Date July 18, 2019

A single dose of oral rimegepant may provide safe, fast, and sustained relief from migraine.

Promising Results for Lacosamide in the Treatment of Chronic Migraine

Publish Date July 17, 2019

Lacosamide, an anti-epileptic drug that inhibits phosphorylation of collapsing response mediator protein 2 and blocks the release of calcitonin gene-related peptide in the trigeminal system, may be effective in the treatment of chronic migraine.

Ubrogepant Efficacious in Acute Migraine Treatment For Those in Whom Triptans Not Effective

Publish Date July 17, 2019

Ubrogepant has demonstrated efficacy in treating acute migraine among individuals for whom triptan has not been effective.

OnabotulinumtoxinA Associated With Fewer Monthly Migraine Days in Those With Chronic Migraine

Publish Date July 17, 2019

OnabotulinumtoxinA has demonstrated efficacy, safety, and tolerability in treating chronic migraine.

FDA Warns of Potential Complications Between CSF Shunts and Implantable Devices

Publish Date July 17, 2019

Individuals with an implantable programmable cerebrospinal fluid shunt are at risk for unintended changes to valve settings through exposure to magnetic fields present in implantable medical devices.

Significant Motor Cortex Degeneration in ALS According to MRS Findings

Publish Date July 17, 2019

Study utilizing metabolic markers and magnetic resonance imaging finds cerebral degeneration is more pronounced in the motor cortex compared with the prefrontal cortex in patients with ALS.

Noninvasive Vagus Nerve Stimulation Effective for Cluster Headache

Publish Date July 17, 2019

Researchers pooled data from 2 randomized, double-blind, placebo-controlled trials and found that noninvasive VNS is effective in aborting attacks in episodic cluster headache.